COMPARISON OF LOSARTAN AND LISINOPRIL EFFECTIVENESS FOR GLOMERULAR AND TUBULAR MARKERS OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE
https://doi.org/10.15829/1728-8800-2015-2-41-45
Abstract
Aim. To compare the losartan and lisinopril influence on glomerular and tubular markers rates of renal dysfunction in I-III functional class (FC) chronic heart failure (CHF). Material and methods. Totally 92 patients studied with I-III FC CHF. First group (I) consisted of 47 patients taking losartan as addition to standard treatment for 6 months; second group (II) — 45 patients took lisinopril. All patients underwent glomerular filtration rate estimation (MDRD GFR) and enzymes levels in urine: alanine transaminase (ALT), aspartat transaminase (AST), alkaline phosphanase (AP). Results. The results showed that GFR <60 ml/min in I and II groups was found in 18 (38,3%) and 17 (37,8%) patients, resp. Baseline data analysis of urine enzymes that characterize functional condition of renal tubules, showed that in GFR <60 ml/min patients there is significant (p<0,05) increase of ALT, AST, AP in urine: for I group patients by 45,2%, 31,8%, 78,2%, resp., and for II group — 43,6%, 33,5%, 73,9%, resp., comparing to the patients with GFR >60 ml/min. Six month treatment with inclusion of losartan and lisinopril led to decrease of enzymes levels in urine to increase of GFR comparing to baseline. Conclusion. GFR and the level of fermenturia are the early predictors of tubular epitelium in kidneys, and can be treated as early predictors of renal dysfunction in CHF. Six month treatment with losartan and lisinopril increases GFR and significantly decreases fermenturia, hence improving the condition of tubular epithelium and showin nephroprotective effect.
About the Authors
U. K. Kamilova
Republic Specialized Scientific-Practical Medical Center of Therapy and Medical Rehabilitation. Tashkent, Uzbekistan
Uzbekistan
Uzbekistan
Z. D. Rasulova
Republic Specialized Scientific-Practical Medical Center of Therapy and Medical Rehabilitation. Tashkent, Uzbekistan
Uzbekistan
Uzbekistan
References
1. Bagshaw SM, Cruz DN, Aspromonte N, et al. Epidemiology of cardio-renal renal syndromes: workgroup statements from the 7 th ADQI Consensus Conference. Nephrol Dial Transplant 2010; 25: 1777-84; 1406-16.
2. Meisinger Chr, Doring A, Lowel H. for KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and allcause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27(10): 1245-50.
3. Ronco C, McCullough PA, Anker SD. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010; 31: 703-11.
4. Soni S, Fahuan Y Ronco C, Cruz DN. Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Biomarkers Med 2009; 3(5): 549-60.
5. Arkhipov EV, Sigitova ON. Structural and functional disorders of nefrocyte cell membranes in chronic kidney disease. Kasan State Medical University 2011; (92) 6: 887-90. Russian (Архипов Е. В., Сигитова О. Н. Структурно-функциональные нарушения клеточных мембран нефроцитов при хронических заболеваниях почек. Казанский медицинский журнал 2011; (92) 6: 887-90).
6. Kopilov VU. Degree of epithelial damage of the renal tubules in patients with coronary heart disease complicated by chronic heart failure, and the possibility of recovery by using different treatments. Bulletin of OSU 2006; 6 (2): 160-3. Russian (Копылов В. Ю. Степень повреждения эпителия почечных канальцев у больных ишемической болезнью сердца, осложненной хронической сердечной недостаточностью, и возможность его восстановления при использовании различных схем лечения. Вестник ОГУ 2006; 6 (2): 160-3).
7. Mavlyanov IR, Akbarova GP, Habilova NL. The state of the tubuloepitelial system of the kidneys in patients with rheumatoid arthritis, depending on the duration of the disease. Preventive medicine 2009; 3: 14-9. Russian (Мавлянов И. Р., Акбарова Г. П.,
8. Хабилова Н. Л. Состояние тубулоэпителиальной системы почек у больных рев-матоидным артритом в зависимости от длительности заболевания. В помощь практикующему врачу. Профилактическая медицина 2009; 3: 14-9).
9. Atroshenko ES. The patient with combine heart failure and renal failure. Medical news 2007; 10: 11-5. Russian (Атрощенко Е. С. Больной с сочетанной хронической сердечной и почечной недостаточностью: проблемы и пути их решения. Медицинские новости 2007; 10: 11-5).
10. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010; 121(23): 2592-600.
11. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney International 2008; 73(9): 1008-16.
12. National Kidney Foundation. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int (Suppl.) 2013; 3: 1-150.
13. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 127-32.
14. Kamishnikov VS. Handbook on clinical and biochemical laboratory diagnostics. Belarus 2002; 2 volumes in 2nd: 463 p. Russian (Камышников В. С. Справочник по клинико-биохимической лабораторной диагностике. Беларусь: в 2 т. 2-е изд., 2002; 463 с).
15. McCullough PA, Haapio M, Mankad S, et al. Prevention of cardio-renal syndromes: workgroup statements from the 7 th ADQI Consensus Conference. Nephrol Dial Transplant 2010; 25: 1777-84.
16. Ozer JS, Dieterle F, Troth S, et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 2010; 28(5): 486-94.
Review
For citations:
Kamilova U.K., Rasulova Z.D. COMPARISON OF LOSARTAN AND LISINOPRIL EFFECTIVENESS FOR GLOMERULAR AND TUBULAR MARKERS OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE. Cardiovascular Therapy and Prevention. 2015;14(2):41-45. (In Russ.) https://doi.org/10.15829/1728-8800-2015-2-41-45
Views:
1172
Email this article 
